Research and Development, Market Development, and Strengthening Production Capabilities
First written in FY2016-Q2. 26 of 34 entries say "Restated". Latest entry: FY2026-H1.
97 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「The total research and development expenses recorded by the Group during the six-month period of the current consolidated fiscal year were ¥810 million. There were no material changes in the status of the Group’s research and development activities during the six-month period of the current consolidated fiscal year.」
Research and development expenses of ¥810 million were recorded, with no material changes in the status of research and development activities. - FY2025-H1RestatedAnnual report
「The total research and development expenses recorded by the Group during the six-month period of the current consolidated fiscal year were ¥898 million. There were no material changes in the status of the Group’s research and development activities during the six-month period of the current consolidated fiscal year.」
There were no material changes in research and development activities, and research and development expenses of ¥898 million were recorded for the six-month period. - FY2024-Q2RestatedAnnual report
「The total research and development expenses recorded by the Group during the six-month period of the current consolidated fiscal year were ¥899 million. There were no material changes in the status of the Group’s research and development activities during the six-month period of the current consolidated fiscal year.」
There were no material changes in research and development activities, and research and development expenses of ¥899 million were recorded for the six-month period. - FY2024-Q1RestatedAnnual report
「The total research and development expenses recorded by the Group during the three-month period of the current consolidated fiscal year were ¥444 million. There were no material changes in the status of the Group’s research and development activities during the three-month period of the current consolidated fiscal year.」
There were no material changes in research and development activities, and research and development expenses of ¥444 million were recorded for the three-month period. - FY2023AdvancedAnnual report
「Research and development expenses for the current consolidated fiscal year were ¥1,436 million, representing 5.0% of net sales.」
Research and development expenses were ¥1,436 million, equivalent to 5.0% of net sales. Specific research and development themes included high-performance and biomass-based monomers in specialty chemicals, microLEDs, flexible displays and next-generation EUV materials in electronic materials, and specialty water-soluble polymers in functional chemicals. - FY2023-Q3RestatedAnnual report
「The total research and development expenses recorded by the Group during the nine-month period of the current consolidated fiscal year were ¥977 million. There were no material changes in the status of the Group’s research and development activities during the nine-month period of the current consolidated fiscal year.」
Research and development expenses of ¥977 million were recorded, with no material changes in the status of research and development activities. - FY2023-Q2RestatedAnnual report
「The total research and development expenses recorded by the Group during the six-month period of the current consolidated fiscal year were ¥649 million. There were no material changes in the status of the Group’s research and development activities during the six-month period of the current consolidated fiscal year.」
Research and development expenses of ¥649 million were recorded, with no material changes in the status of research and development activities. - FY2023-Q1RestatedAnnual report
「The total research and development expenses recorded by the Group during the three-month period of the current consolidated fiscal year were ¥336 million. There were no material changes in the status of the Group’s research and development activities during the three-month period of the current consolidated fiscal year.」
Research and development expenses for the three-month period were ¥336 million, with no material changes in the status of research and development activities. - FY2022AdvancedAnnual report
「Research and development expenses for the current consolidated fiscal year were ¥1,233 million, representing 3.8% of net sales.」
Research and development expenses were ¥1,233 million, equivalent to 3.8% of net sales. Specific research and development themes included specialty monomers made from biomass raw materials, microLEDs, monomers for EUV resists, and materials related to flexible displays. - FY2022-Q3RestatedAnnual report
「The total research and development expenses recorded by the Group during the nine-month period of the current consolidated fiscal year were ¥924 million. There were no material changes in the status of the Group’s research and development activities during the nine-month period of the current consolidated fiscal year.」
Research and development expenses for the nine-month period were ¥924 million, with no material changes in the status of research and development activities. - FY2022-Q2RestatedAnnual report
「The total research and development expenses recorded by our Group during the second quarter cumulative period were ¥617 million. There were no material changes in the status of our Group's research and development activities during the second quarter cumulative period.」
The company stated that research and development expenses for the second quarter cumulative period were ¥617 million and that there were no material changes in its research and development activities. - FY2022-Q1RestatedAnnual report
「The total research and development expenses recorded by our Group during the first quarter cumulative period were ¥308 million. There were no material changes in the status of our Group's research and development activities during the first quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and recorded research and development expenses of ¥308 million for the first quarter cumulative period. - FY2021AdvancedAnnual report
「Research and development expenses for the fiscal year were ¥1,289 million, equivalent to 3.7% of revenue.」
Research and development expenses were ¥1,289 million, equivalent to 3.7% of revenue. Specific research and development projects have also taken shape, including biomass-derived specialty acrylate esters, microLEDs, monomers for EUV resists and biocompatible materials. - FY2021-Q3RestatedAnnual report
「The total research and development expenses recorded by our Group during the third quarter cumulative period were ¥973 million. There were no material changes in the status of our Group's research and development activities during the third quarter cumulative period.」
The company stated that research and development expenses for the third quarter cumulative period were ¥973 million and that there were no material changes in its research and development activities. - FY2021-Q2RestatedAnnual report
「The total research and development expenses recorded by our Group during the second quarter cumulative period were ¥660 million. There were no material changes in the status of our Group's research and development activities during the second quarter cumulative period.」
The company stated that research and development expenses for the second quarter cumulative period were ¥660 million and that there were no material changes in its research and development activities. - FY2021-Q1RestatedAnnual report
「The total research and development expenses recorded by our Group during the first quarter cumulative period were ¥297 million. There were no material changes in the status of our Group's research and development activities during the first quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and recorded research and development expenses of ¥297 million for the first quarter cumulative period. - FY2020AdvancedAnnual report
「This year, we are also constructing a new research building, Creo Research Center, at the Osaka Business Office as a research and development base, and are establishing the research environment needed to further accelerate the creation of new businesses. Research and development expenses for the fiscal year were ¥1,210 million, equivalent to 4.2% of revenue.」
A new research building, Creo Research Center, was constructed at the Osaka Business Office to establish a research and development base. Research and development expenses were ¥1,210 million, equivalent to 4.2% of revenue. - FY2020-Q3RestatedAnnual report
「The total research and development expenses recorded by our Group during the third quarter cumulative period were ¥802 million. There were no material changes in the status of our Group's research and development activities during the third quarter cumulative period.」
The company stated that research and development expenses for the third quarter cumulative period were ¥802 million and that there were no material changes in its research and development activities. - FY2020-Q2RestatedAnnual report
「The total research and development expenses recorded by our Group during the second quarter cumulative period were ¥532 million. There were no material changes in the status of our Group's research and development activities during the second quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and recorded research and development expenses of ¥532 million for the second quarter cumulative period. - FY2020-Q1RestatedAnnual report
「The total research and development expenses recorded by our Group during the first quarter cumulative period were ¥257 million. There were no material changes in the status of our Group's research and development activities during the first quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and recorded research and development expenses of ¥257 million for the first quarter cumulative period. - FY2019AdvancedAnnual report
「With regard to research and development activities, sales development personnel and researchers work closely together to respond to market needs, enabling the rapid provision of products that leverage the company's core technologies and meet market requirements. Research and development expenses for the fiscal year were ¥1,064 million, equivalent to 3.7% of revenue.」
The company identified collaboration between sales development personnel and researchers as its approach to research and development. Annual research and development expenses were ¥1,064 million, equivalent to 3.7% of revenue. - FY2019-Q3RestatedAnnual report
「The total research and development expenses recorded by our Group during the third quarter cumulative period were ¥774 million. There were no material changes in the status of our Group's research and development activities during the third quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥774 million for the third quarter cumulative period. - FY2019-Q2RestatedAnnual report
「In line with this plan, we aim to achieve our objectives by strengthening research and development, market development, production capabilities and our management infrastructure. The total research and development expenses recorded by our Group during the second quarter cumulative period were ¥495 million. There were no material changes in the status of our Group's research and development activities during the second quarter cumulative period.」
There were no material changes in the policy of using the strengthening of research and development, market development, production capabilities and our management infrastructure as means of achieving the plans, and research and development expenses were ¥495 million. - FY2019-Q1RestatedAnnual report
「In line with this plan, we aim to achieve our objectives by strengthening research and development, market development, production capabilities and our management infrastructure. The total research and development expenses recorded by our Group during the first quarter cumulative period were ¥240 million. There were no material changes in the status of our Group's research and development activities during the first quarter cumulative period.」
There were no material changes in the policy of using the strengthening of research and development, market development, production capabilities and our management infrastructure as means of achieving the plans, and research and development expenses were ¥240 million. - FY2018AdvancedAnnual report
「Research and development expenses for the fiscal year were ¥1,003 million, equivalent to 3.4% of revenue.」
Annual research and development expenses were ¥1,003 million, equivalent to 3.4% of revenue. The company also identified specific research and development projects, including new monomers for UV inkjet applications, materials for 4K, 8K and flexible displays, and anti-fogging and hydrophilic materials. - FY2018-Q3RestatedAnnual report
「The total research and development expenses recorded by our Group during the third quarter cumulative period were ¥723 million. There were no material changes in the status of our Group's research and development activities during the third quarter cumulative period.」
The company stated that research and development expenses for the third quarter cumulative period were ¥723 million and that there were no material changes in its research and development activities. - FY2018-Q2RestatedAnnual report
「The total research and development expenses recorded by our Group during the second quarter cumulative period were ¥474 million. There were no material changes in the status of our Group's research and development activities during the second quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and recorded research and development expenses of ¥474 million. - FY2018-Q1RestatedAnnual report
「The total research and development expenses recorded by our Group during the first quarter cumulative period were ¥230 million. There were no material changes in the status of our Group's research and development activities during the first quarter cumulative period.」
The company stated that there were no material changes in its research and development activities and that first-quarter research and development expenses were ¥230 million. - FY2017-Q3RestatedAnnual report
「In line with this plan, we aim to achieve our objectives by strengthening research and development, market development, production capabilities and our management infrastructure. The total research and development expenses recorded by our Group during the third quarter cumulative period were ¥682 million. There were no material changes in the status of our Group's research and development activities during the third quarter cumulative period.」
The company continues to strengthen research and development, market development, production capabilities and its management infrastructure as means of achieving its plans. Research and development expenses for the third quarter cumulative period were ¥682 million, and it stated that there were no material changes in its research and development activities. - FY2017-Q2RestatedAnnual report
「The total research and development expenses recorded by our Group during the second quarter cumulative period were ¥450 million. There were no material changes in the status of our Group's research and development activities during the second quarter cumulative period.」
The company stated that research and development expenses for the second quarter cumulative period were ¥450 million and that there were no material changes in its research and development activities. - FY2017-Q1RestatedAnnual report
「The total research and development expenses recorded by our Group during the first quarter cumulative period were ¥218 million. There were no material changes in the status of our Group's research and development activities during the first quarter cumulative period.」
The company stated that research and development expenses for the first quarter cumulative period were ¥218 million and that there were no material changes in its research and development activities. - FY2016AdvancedAnnual report
「Research and development expenses for the fiscal year were ¥950 million, equivalent to 4.0% of revenue.」
Annual research and development expenses were ¥950 million, equivalent to 4.0% of revenue, with specific research and development projects underway in the chemicals, electronic materials and functional chemicals fields. - FY2016-Q3RestatedAnnual report
「In each business, we aim to achieve our plans by strengthening research and development, market development and production capabilities as described below.」
The company continues to strengthen research and development, market development and production capabilities as means of achieving its plans. Research and development expenses for the nine-month cumulative period were ¥699 million. - FY2016-Q2First statedAnnual report
「In each business, we aim to achieve our plans by strengthening research and development, market development and production capabilities as described below.」
The company identifies the strengthening of research and development, market development and production capabilities as means of achieving its plans for each business.